{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-001203","form_type":"8-K","ticker":"ELDN","cik":"0001404281","company_name":"Eledon Pharmaceuticals, Inc.","filed_at":"2022-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.321956+00:00","generated_at":"2026-06-27T18:11:28.700623+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Eledon exchanges 550K common for Series X1 preferred; convertible at 55.56 per share","bullets":["Exchanged 550,000 common shares for 9,899.99 Series X1 preferred shares with BVF entities.","Series X1 preferred convertible into ~6.55M shares at 55.5556 common per preferred (post-reverse split).","After exchange, common outstanding: 13,756,788; Series X1 preferred outstanding: ~117,970 shares.","Exchange exempt under Section 3(a)(9) of Securities Act; no registration required."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-001203","json":"https://secwatch.observer/filing/0001564590-22-001203.json","markdown":"https://secwatch.observer/filing/0001564590-22-001203.md","text":"https://secwatch.observer/filing/0001564590-22-001203.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404281/000156459022001203/0001564590-22-001203-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404281/000156459022001203/eldn-8k_20220111.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T18:11:28.700623+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}